Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Sign In

Login with LinkedIn


Sign In securely

Haven't registered yet?

Online Surveys
2013 Biotech Bust
Share |

2013 Biotech Boom a Bust for Women

While women earn more than half the bachelor degrees and PhDs in the biological sciences, they remain poorly represented in the leadership of start-ups. Based on analysis performed by AWIS, we find that while 2013 was a banner year for biotech initial public offerings (IPOs), it was a bust for women.
  • Only one company had a female CEO
  • Many companies had no women in the C suite or on their board of directors.

**Not all firms disclose lists of science/clinical advisory boards
**There are several women CEOs in biotech companies, but none of these companies are IPOs.
**Sources: (data accurate as of 3.27.14) "A Quick Glance At The Biotech IPO Boom" by Matthew Herper, Forbes Staff. 8/13/13. IPO Listing
Fierce IPO Frenzy

© 2016 AWIS
Association for Women in Science
1667 K Street NW, Suite 800
Washington, DC 20006
202.588.8175  |